Lung cancer drug lorbrena under Post-Market safety review
NCT ID NCT03844464
First seen Nov 01, 2025 · Last updated Jun 21, 2026 · Updated 33 times
Summary
This completed study tracked 1290 lung cancer patients taking Lorbrena to see how often nervous system and liver side effects occur. Researchers aimed to identify factors that might increase these risks. The study does not test how well the drug works, only its safety in real-world use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
3-22-7, Yoyogi, Shibuya-ku
Tokyo, 151-8589, Japan
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Lorbrena (lorlatinib)
What this could lead to
If successful, this study could provide better understanding of Lorbrena's side effects, helping doctors manage them more safely.
What could go wrong
This is an observational study, not a test of whether Lorbrena works. It only looks at side effects, not effectiveness.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.